| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 2.58e-13 | 114 | 51 | 10 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 6.08e-13 | 124 | 51 | 10 | GO:0101005 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 1.67e-12 | 137 | 51 | 10 | GO:0019783 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 4.85e-11 | 192 | 51 | 10 | GO:0008234 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 8.24e-08 | 86 | 51 | 6 | GO:0004197 | |
| GeneOntologyMolecularFunction | histone H2A deubiquitinase activity | 3.12e-07 | 6 | 51 | 3 | GO:0140950 | |
| GeneOntologyMolecularFunction | histone deubiquitinase activity | 8.71e-07 | 8 | 51 | 3 | GO:0140934 | |
| GeneOntologyMolecularFunction | peptidase activity | 5.04e-06 | 654 | 51 | 10 | GO:0008233 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 2.02e-05 | 21 | 51 | 3 | GO:1990380 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 2.68e-05 | 23 | 51 | 3 | GO:0010485 | |
| GeneOntologyMolecularFunction | histone H2B deubiquitinase activity | 3.82e-05 | 4 | 51 | 2 | GO:0140936 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.90e-04 | 229 | 51 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.00e-04 | 51 | 51 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 3.47e-04 | 11 | 51 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 3.47e-04 | 11 | 51 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.75e-04 | 55 | 51 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 4.15e-04 | 12 | 51 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 4.15e-04 | 12 | 51 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | CCR1 chemokine receptor binding | 4.15e-04 | 12 | 51 | 2 | GO:0031726 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.85e-04 | 60 | 51 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | CCR5 chemokine receptor binding | 4.90e-04 | 13 | 51 | 2 | GO:0031730 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 5.71e-04 | 14 | 51 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | K63-linked deubiquitinase activity | 7.50e-04 | 16 | 51 | 2 | GO:0061578 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 7.64e-04 | 430 | 51 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.04e-03 | 78 | 51 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.35e-03 | 188 | 51 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 1.56e-03 | 23 | 51 | 2 | GO:0016004 | |
| GeneOntologyMolecularFunction | histone reader activity | 2.00e-03 | 26 | 51 | 2 | GO:0140566 | |
| GeneOntologyMolecularFunction | lipase activator activity | 2.16e-03 | 27 | 51 | 2 | GO:0060229 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.26e-03 | 102 | 51 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 2.38e-03 | 104 | 51 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 4.92e-03 | 41 | 51 | 2 | GO:0140463 | |
| GeneOntologyMolecularFunction | chemokine activity | 7.53e-03 | 51 | 51 | 2 | GO:0008009 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 7.82e-03 | 52 | 51 | 2 | GO:0035255 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 8.41e-03 | 54 | 51 | 2 | GO:0042056 | |
| GeneOntologyMolecularFunction | CCR chemokine receptor binding | 9.02e-03 | 56 | 51 | 2 | GO:0048020 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 4.80e-13 | 125 | 51 | 10 | GO:0016579 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 2.01e-12 | 144 | 51 | 10 | GO:0070646 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP6 USP2 GMCL2 USP8 USP22 USP51 USP11 USP4 USP27X USP15 USP3 | 2.86e-05 | 1009 | 51 | 11 | GO:0070647 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.59e-05 | 4 | 51 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 4.95e-05 | 540 | 51 | 8 | GO:1903706 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP6 USP2 GMCL2 USP8 USP22 USP51 USP11 USP4 USP27X USP15 USP3 | 5.05e-05 | 1074 | 51 | 11 | GO:0043687 |
| GeneOntologyBiologicalProcess | retinal blood vessel morphogenesis | 8.93e-05 | 6 | 51 | 2 | GO:0061304 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.66e-04 | 8 | 51 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 1.94e-04 | 116 | 51 | 4 | GO:0045670 | |
| GeneOntologyBiologicalProcess | retina vasculature morphogenesis in camera-type eye | 3.25e-04 | 11 | 51 | 2 | GO:0061299 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 3.25e-04 | 11 | 51 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 4.20e-04 | 59 | 51 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.59e-04 | 13 | 51 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.59e-04 | 13 | 51 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | astrocyte cell migration | 4.59e-04 | 13 | 51 | 2 | GO:0043615 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 5.28e-04 | 151 | 51 | 4 | GO:1902106 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 6.07e-04 | 278 | 51 | 5 | GO:0031503 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 6.38e-04 | 429 | 51 | 6 | GO:1902105 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 6.41e-04 | 159 | 51 | 4 | GO:1903707 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 6.87e-04 | 162 | 51 | 4 | GO:0030316 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 7.12e-04 | 288 | 51 | 5 | GO:0045637 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.17e-04 | 7 | 50 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 1.56e-04 | 8 | 50 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | microfibril | 4.30e-04 | 13 | 50 | 2 | GO:0001527 | |
| HumanPheno | Abnormal upper to lower segment ratio | 2.42e-05 | 3 | 15 | 2 | HP:0012772 | |
| Domain | USP_CS | 1.37e-15 | 66 | 50 | 10 | IPR018200 | |
| Domain | USP_1 | 2.55e-15 | 70 | 50 | 10 | PS00972 | |
| Domain | UCH | 2.97e-15 | 71 | 50 | 10 | PF00443 | |
| Domain | USP_2 | 2.97e-15 | 71 | 50 | 10 | PS00973 | |
| Domain | USP_3 | 3.44e-15 | 72 | 50 | 10 | PS50235 | |
| Domain | USP_dom | 3.44e-15 | 72 | 50 | 10 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 3.44e-15 | 72 | 50 | 10 | IPR001394 | |
| Domain | Ub_USP-typ | 7.21e-08 | 4 | 50 | 3 | IPR028135 | |
| Domain | Ubiquitin_3 | 7.21e-08 | 4 | 50 | 3 | PF14836 | |
| Domain | DUSP | 3.59e-07 | 6 | 50 | 3 | SM00695 | |
| Domain | DUSP | 3.59e-07 | 6 | 50 | 3 | PF06337 | |
| Domain | - | 6.27e-07 | 7 | 50 | 3 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 6.27e-07 | 7 | 50 | 3 | IPR006615 | |
| Domain | DUSP | 6.27e-07 | 7 | 50 | 3 | PS51283 | |
| Domain | zf-UBP | 6.44e-06 | 14 | 50 | 3 | PF02148 | |
| Domain | ZF_UBP | 6.44e-06 | 14 | 50 | 3 | PS50271 | |
| Domain | Znf_UBP | 6.44e-06 | 14 | 50 | 3 | IPR001607 | |
| Domain | USP_C | 2.10e-05 | 3 | 50 | 2 | IPR029346 | |
| Domain | USP7_C2 | 2.10e-05 | 3 | 50 | 2 | PF14533 | |
| Domain | FBN | 2.10e-05 | 3 | 50 | 2 | IPR011398 | |
| Domain | EGF_1 | 5.87e-05 | 255 | 50 | 6 | PS00022 | |
| Domain | EGF_2 | 7.26e-05 | 265 | 50 | 6 | PS01186 | |
| Domain | TB | 1.46e-04 | 7 | 50 | 2 | PF00683 | |
| Domain | LDLR_class-A_CS | 1.66e-04 | 40 | 50 | 3 | IPR023415 | |
| Domain | Enhancer_polycomb-like_N | 1.95e-04 | 8 | 50 | 2 | IPR019542 | |
| Domain | - | 1.95e-04 | 8 | 50 | 2 | 3.90.290.10 | |
| Domain | EPL1 | 1.95e-04 | 8 | 50 | 2 | PF10513 | |
| Domain | Ldl_recept_a | 2.37e-04 | 45 | 50 | 3 | PF00057 | |
| Domain | TB | 2.50e-04 | 9 | 50 | 2 | PS51364 | |
| Domain | TB_dom | 2.50e-04 | 9 | 50 | 2 | IPR017878 | |
| Domain | - | 2.53e-04 | 46 | 50 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.87e-04 | 48 | 50 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.05e-04 | 49 | 50 | 3 | IPR002172 | |
| Domain | LDLa | 3.05e-04 | 49 | 50 | 3 | SM00192 | |
| Domain | LDLRA_2 | 3.05e-04 | 49 | 50 | 3 | PS50068 | |
| Domain | EGF | 4.04e-04 | 235 | 50 | 5 | SM00181 | |
| Domain | EGF-like_dom | 5.25e-04 | 249 | 50 | 5 | IPR000742 | |
| Domain | EGF-like_CS | 6.50e-04 | 261 | 50 | 5 | IPR013032 | |
| Domain | PWWP | 1.29e-03 | 20 | 50 | 2 | SM00293 | |
| Domain | EPHD | 1.57e-03 | 22 | 50 | 2 | PS51805 | |
| Domain | PWWP | 1.71e-03 | 23 | 50 | 2 | PF00855 | |
| Domain | PWWP_dom | 1.71e-03 | 23 | 50 | 2 | IPR000313 | |
| Domain | PWWP | 1.87e-03 | 24 | 50 | 2 | PS50812 | |
| Domain | cEGF | 2.19e-03 | 26 | 50 | 2 | IPR026823 | |
| Domain | cEGF | 2.19e-03 | 26 | 50 | 2 | PF12662 | |
| Domain | Bromodomain_CS | 2.19e-03 | 26 | 50 | 2 | IPR018359 | |
| Domain | EGF_CA | 2.36e-03 | 99 | 50 | 3 | PS01187 | |
| Domain | BROMODOMAIN_1 | 4.41e-03 | 37 | 50 | 2 | PS00633 | |
| Domain | EGF-like_Ca-bd_dom | 4.46e-03 | 124 | 50 | 3 | IPR001881 | |
| Domain | Bromodomain | 4.64e-03 | 38 | 50 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.39e-03 | 41 | 50 | 2 | PS50014 | |
| Domain | BROMO | 5.65e-03 | 42 | 50 | 2 | SM00297 | |
| Domain | Bromodomain | 5.65e-03 | 42 | 50 | 2 | IPR001487 | |
| Domain | - | 5.65e-03 | 42 | 50 | 2 | 1.20.920.10 | |
| Domain | LamG | 6.18e-03 | 44 | 50 | 2 | SM00282 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 5.48e-07 | 191 | 37 | 7 | MM15289 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.46e-06 | 221 | 37 | 7 | M27578 | |
| Pathway | REACTOME_DEUBIQUITINATION | 4.52e-06 | 262 | 37 | 7 | MM15286 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.07e-05 | 299 | 37 | 7 | M27574 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 4.65e-04 | 58 | 37 | 3 | MM14978 | |
| Pubmed | 3.12e-17 | 81 | 51 | 10 | 12838346 | ||
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 3.63e-14 | 15 | 51 | 6 | 9827704 | |
| Pubmed | 8.79e-13 | 147 | 51 | 9 | 29576527 | ||
| Pubmed | Photocaged Cell-Permeable Ubiquitin Probe for Temporal Profiling of Deubiquitinating Enzymes. | 5.15e-10 | 64 | 51 | 6 | 33141564 | |
| Pubmed | 2.02e-09 | 36 | 51 | 5 | 22626734 | ||
| Pubmed | Structural variability of the ubiquitin specific protease DUSP-UBL double domains. | 2.97e-09 | 3 | 51 | 3 | 22001210 | |
| Pubmed | Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11. | 2.97e-09 | 3 | 51 | 3 | 26503449 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP6 USP2 USP8 USP22 USP11 USP4 ALDH9A1 USP27X USP15 USP3 ZMYM4 NMD3 | 1.79e-08 | 1005 | 51 | 12 | 19615732 |
| Pubmed | Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. | 8.18e-08 | 28 | 51 | 4 | 22118674 | |
| Pubmed | Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin. | 1.63e-07 | 33 | 51 | 4 | 30323974 | |
| Pubmed | USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. | 1.65e-07 | 8 | 51 | 3 | 22706160 | |
| Pubmed | USP11 Is a Negative Regulator to γH2AX Ubiquitylation by RNF8/RNF168. | 1.65e-07 | 8 | 51 | 3 | 26507658 | |
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 22195557 | ||
| Pubmed | USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA. | 6.47e-07 | 12 | 51 | 3 | 27801882 | |
| Pubmed | 1.33e-06 | 15 | 51 | 3 | 9139699 | ||
| Pubmed | 1.99e-06 | 17 | 51 | 3 | 29299163 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12399449 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11943477 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21851253 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35451730 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12429739 | ||
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 2.11e-06 | 2 | 51 | 2 | 24833718 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 2.11e-06 | 2 | 51 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 2.11e-06 | 2 | 51 | 2 | 21440062 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15131124 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24403160 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15464227 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 28680963 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24265020 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 2.11e-06 | 2 | 51 | 2 | 12524050 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20529844 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 2.11e-06 | 2 | 51 | 2 | 25524144 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 2.11e-06 | 2 | 51 | 2 | 20404337 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24333487 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23133647 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 2.11e-06 | 2 | 51 | 2 | 8791520 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 8120105 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35419902 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 2.11e-06 | 2 | 51 | 2 | 8307578 | |
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 2.11e-06 | 2 | 51 | 2 | 16407178 | |
| Pubmed | Isolation and characterization of the mouse ubiquitin-specific protease Usp15. | 2.11e-06 | 2 | 51 | 2 | 12532266 | |
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 2.11e-06 | 2 | 51 | 2 | 10504303 | |
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 2.11e-06 | 2 | 51 | 2 | 1852206 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10359653 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 2.11e-06 | 2 | 51 | 2 | 7744963 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19055602 | ||
| Pubmed | NETO1 Regulates Postsynaptic Kainate Receptors in CA3 Interneurons During Circuit Maturation. | 2.11e-06 | 2 | 51 | 2 | 31044365 | |
| Pubmed | Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction. | 2.11e-06 | 2 | 51 | 2 | 30770891 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 2.11e-06 | 2 | 51 | 2 | 18006876 | |
| Pubmed | 2.39e-06 | 18 | 51 | 3 | 30410068 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.39e-06 | 18 | 51 | 3 | 39040056 | |
| Pubmed | 5.88e-06 | 24 | 51 | 3 | 31911859 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10825173 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15728180 | ||
| Pubmed | Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. | 6.32e-06 | 3 | 51 | 2 | 20400950 | |
| Pubmed | Phosphorylation of USP15 and USP4 Regulates Localization and Spliceosomal Deubiquitination. | 6.32e-06 | 3 | 51 | 2 | 31330151 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26720915 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 37332045 | ||
| Pubmed | Three human homologs of a murine gene encoding an inhibitor of stem cell proliferation. | 6.32e-06 | 3 | 51 | 2 | 2271120 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 28235897 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 30201140 | ||
| Pubmed | Structures of human genes coding for cytokine LD78 and their expression. | 6.32e-06 | 3 | 51 | 2 | 1694014 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 20855508 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 7.54e-06 | 26 | 51 | 3 | 34189436 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 30199766 | ||
| Pubmed | Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3. | 1.26e-05 | 4 | 51 | 2 | 27109512 | |
| Pubmed | Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. | 1.26e-05 | 4 | 51 | 2 | 2320111 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20223588 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 26277340 | ||
| Pubmed | Requirement of MIP-1 alpha for an inflammatory response to viral infection. | 1.26e-05 | 4 | 51 | 2 | 7667639 | |
| Pubmed | The chemokine CCL3 promotes experimental liver fibrosis in mice. | 1.26e-05 | 4 | 51 | 2 | 23799074 | |
| Pubmed | Role of macrophage inflammatory protein-1alpha in T-cell-mediated immunity to viral infection. | 1.26e-05 | 4 | 51 | 2 | 14581577 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 2216738 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12429738 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15784598 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20551286 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 26472813 | ||
| Pubmed | CpG domains downstream of TSSs promote high levels of gene expression. | 1.26e-05 | 4 | 51 | 2 | 24413563 | |
| Pubmed | Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production. | 1.26e-05 | 4 | 51 | 2 | 15760677 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 38661718 | ||
| Pubmed | The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers. | 1.26e-05 | 4 | 51 | 2 | 30279500 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 8292385 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 16009684 | ||
| Pubmed | Type 1 T-cell responses in chlamydial lung infections are associated with local MIP-1alpha response. | 1.26e-05 | 4 | 51 | 2 | 20622889 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 7779098 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 35613826 | ||
| Pubmed | Regulatory T cells were recruited by CCL3 to promote cryo-injured muscle repair. | 1.26e-05 | 4 | 51 | 2 | 30321562 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 36550354 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20140197 | ||
| Pubmed | Human eye development is characterized by coordinated expression of fibrillin isoforms. | 1.26e-05 | 4 | 51 | 2 | 25406291 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20100934 | ||
| Pubmed | The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory. | 1.26e-05 | 4 | 51 | 2 | 26511387 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 27132940 | ||
| Pubmed | Development and pathology of Fasciola hepatica in CCL3-deficient mice. | 1.26e-05 | 4 | 51 | 2 | 20643506 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12370381 | ||
| Pubmed | MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. | 1.26e-05 | 4 | 51 | 2 | 9541500 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20195359 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12511416 | ||
| Pubmed | Otitis Media and Nasopharyngeal Colonization in ccl3-/- Mice. | 1.26e-05 | 4 | 51 | 2 | 28847849 | |
| Interaction | ATXN7L3 interactions | 2.22e-07 | 53 | 51 | 5 | int:ATXN7L3 | |
| Interaction | USP28 interactions | 3.99e-07 | 113 | 51 | 6 | int:USP28 | |
| Interaction | RNF19B interactions | 2.12e-06 | 83 | 51 | 5 | int:RNF19B | |
| Interaction | PLA2G2A interactions | 2.52e-06 | 38 | 51 | 4 | int:PLA2G2A | |
| Interaction | USP51 interactions | 4.17e-06 | 43 | 51 | 4 | int:USP51 | |
| Interaction | TCEAL2 interactions | 2.98e-05 | 24 | 51 | 3 | int:TCEAL2 | |
| Interaction | USP21 interactions | 5.34e-05 | 161 | 51 | 5 | int:USP21 | |
| Interaction | SUPT20H interactions | 6.93e-05 | 87 | 51 | 4 | int:SUPT20H | |
| Interaction | LTBP1 interactions | 8.62e-05 | 92 | 51 | 4 | int:LTBP1 | |
| Interaction | USP27X interactions | 1.12e-04 | 37 | 51 | 3 | int:USP27X | |
| Interaction | MUC12 interactions | 1.31e-04 | 7 | 51 | 2 | int:MUC12 | |
| Interaction | TAF5L interactions | 1.55e-04 | 107 | 51 | 4 | int:TAF5L | |
| Interaction | ATXN7 interactions | 1.66e-04 | 109 | 51 | 4 | int:ATXN7 | |
| Cytoband | 14q24.3 | 4.85e-03 | 93 | 51 | 2 | 14q24.3 | |
| Cytoband | Xp11.23 | 5.06e-03 | 95 | 51 | 2 | Xp11.23 | |
| Cytoband | 17q12 | 5.48e-03 | 99 | 51 | 2 | 17q12 | |
| GeneFamily | Ubiquitin specific peptidases | 6.01e-18 | 56 | 35 | 10 | 366 | |
| GeneFamily | PWWP domain containing | 8.21e-04 | 22 | 35 | 2 | 1147 | |
| GeneFamily | Chemokine ligands|Endogenous ligands | 3.42e-03 | 45 | 35 | 2 | 483 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 9.97e-03 | 78 | 35 | 2 | 262 | |
| GeneFamily | PHD finger proteins | 1.31e-02 | 90 | 35 | 2 | 88 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP | 6.58e-06 | 19 | 51 | 3 | M12084 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.76e-06 | 176 | 51 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.01e-05 | 177 | 51 | 4 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 178 | 51 | 4 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 178 | 51 | 4 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.35e-05 | 180 | 51 | 4 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 5.46e-05 | 181 | 51 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 185 | 51 | 4 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-05 | 185 | 51 | 4 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 186 | 51 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 187 | 51 | 4 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 187 | 51 | 4 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 187 | 51 | 4 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-05 | 188 | 51 | 4 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-05 | 188 | 51 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 189 | 51 | 4 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 189 | 51 | 4 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | COVID-19_Mild-Treg|COVID-19_Mild / Disease condition and Cell class | 6.46e-05 | 189 | 51 | 4 | f0fceb5f87ca260bfe038c0db3487a6d2e1b0a6e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.59e-05 | 190 | 51 | 4 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-05 | 191 | 51 | 4 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 6.73e-05 | 191 | 51 | 4 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / Disease condition and Cell class | 6.73e-05 | 191 | 51 | 4 | 06fdd76ea13b93e29959c745698b57af6746aaeb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-05 | 191 | 51 | 4 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 6.87e-05 | 192 | 51 | 4 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 51 | 4 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 51 | 4 | c3707243c5590d852c9f28429c96f50a1fa6b0dc | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 51 | 4 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 51 | 4 | 0e7e55505bd5454d7cf952a63fdcb46ec76f1973 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.87e-05 | 192 | 51 | 4 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-05 | 192 | 51 | 4 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.87e-05 | 192 | 51 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.87e-05 | 192 | 51 | 4 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-05 | 193 | 51 | 4 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 193 | 51 | 4 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 193 | 51 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 193 | 51 | 4 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 193 | 51 | 4 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 193 | 51 | 4 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 193 | 51 | 4 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.15e-05 | 194 | 51 | 4 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.15e-05 | 194 | 51 | 4 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.15e-05 | 194 | 51 | 4 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 7.29e-05 | 195 | 51 | 4 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.29e-05 | 195 | 51 | 4 | 773728703bc8969bff0e1de58fe3e1631add0a0a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-05 | 197 | 51 | 4 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.58e-05 | 197 | 51 | 4 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.89e-05 | 199 | 51 | 4 | 6c0354f57883330c685a8d9d5d3014ace7eca584 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 7.89e-05 | 199 | 51 | 4 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-04 | 95 | 51 | 3 | 3d6b97576ce4e7a3e495cbc7246ea8c0b2a386f7 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 2.36e-04 | 20 | 51 | 2 | f245d0c009d45a3bd18cd970d82f10da2936c9f5 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 109 | 51 | 3 | f4b9fe5335cabe48a5fae7ec51bab0d7bdb17321 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 109 | 51 | 3 | a84a4a3ac19692e5595b9820d49e12ae336f4bbf | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 109 | 51 | 3 | f7d7b67f7585f2ae0ac905bcf3980264cf9234b8 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 109 | 51 | 3 | f007fa3dc92d6c8543585e47ccec218263b3266e | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 109 | 51 | 3 | 8460683529759585bd363d10a16ee13af2bd4e28 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_1|COVID-19_Convalescent / Disease condition and Cell class | 3.72e-04 | 25 | 51 | 2 | 00e8c78c4fcc961eb37ea5838f4203ae32cf7faa | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.96e-04 | 125 | 51 | 3 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | f1f24b06d301c266226d1a59dd28585f5ac68f29 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | fe6900eb37e4f09465a1276586c73dd38545fa2a | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | 1ac4cc747e466bc79e33b97608b19ad29a7a6a41 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | 2de551d7a8765afec1da8852727c79fec90f45f8 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_TIP|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.05e-04 | 126 | 51 | 3 | 3d507f829882d043f633db2612b76936e2042445 | |
| ToppCell | Control-Classical_Monocyte-|Control / Disease condition and Cell class | 4.44e-04 | 130 | 51 | 3 | e55f522dab5a6c3af30ad87ac8b32166f660c314 | |
| ToppCell | Control-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 4.44e-04 | 130 | 51 | 3 | 4433b40b099845f113993b6ecf85ec594b4b9219 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.85e-04 | 134 | 51 | 3 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.39e-04 | 139 | 51 | 3 | a542ef99ba57f364ea9707b3119e11f5a240034c | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 141 | 51 | 3 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 141 | 51 | 3 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 142 | 51 | 3 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-04 | 144 | 51 | 3 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | PBMC-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 6.10e-04 | 145 | 51 | 3 | 23a9a4fd1934c4a38d9259105c1fdbac459575cb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.60e-04 | 149 | 51 | 3 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.12e-04 | 153 | 51 | 3 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-04 | 153 | 51 | 3 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.12e-04 | 153 | 51 | 3 | 2c46183481e6d5a7fa190a743062509465f88e56 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.12e-04 | 153 | 51 | 3 | decc4f3098a9374a6b65c015a9d36380986290bf | |
| ToppCell | PBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 7.12e-04 | 153 | 51 | 3 | db1a6914f2033fb0748e0523cffe5d6dc4e901be | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.12e-04 | 153 | 51 | 3 | 36a28805c0545c2f410c74a6ca0a70d840e75715 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.26e-04 | 154 | 51 | 3 | d2aa24c593a1c0c6f186b74a18438b64b4e59701 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.26e-04 | 154 | 51 | 3 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 155 | 51 | 3 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-04 | 156 | 51 | 3 | ea9223bb6450b22df11efa1705ab72dab005244a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-04 | 156 | 51 | 3 | 586b5509074c4cc359e9e31a968c2ded71c994ca | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-04 | 157 | 51 | 3 | e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.68e-04 | 157 | 51 | 3 | 3aa12913410925d577205cb6f1f5ae6bea20d93f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.96e-04 | 159 | 51 | 3 | 6c0ef40f64d2e35eaae3d0002e3c1f22d1239736 | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 7.96e-04 | 159 | 51 | 3 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.96e-04 | 159 | 51 | 3 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.96e-04 | 159 | 51 | 3 | 745a59c33b04620c5329bdd50e74a8e611f2dc55 | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 8.26e-04 | 161 | 51 | 3 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 8.26e-04 | 161 | 51 | 3 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 8.26e-04 | 161 | 51 | 3 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 8.26e-04 | 161 | 51 | 3 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.41e-04 | 162 | 51 | 3 | e5fc80ab19d513af6a7e677a5e67bfebca2e963b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-04 | 162 | 51 | 3 | ca30d9bf61f4133566fdc91c7996e130ea554d01 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.41e-04 | 162 | 51 | 3 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| Disease | glioblastoma (implicated_via_orthology) | 3.59e-07 | 9 | 49 | 3 | DOID:3068 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 8.10e-06 | 3 | 49 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 1.62e-05 | 4 | 49 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Chagas disease (biomarker_via_orthology) | 4.04e-05 | 6 | 49 | 2 | DOID:12140 (biomarker_via_orthology) | |
| Disease | crescentic glomerulonephritis (biomarker_via_orthology) | 7.52e-05 | 8 | 49 | 2 | DOID:13139 (biomarker_via_orthology) | |
| Disease | anterior uveitis (biomarker_via_orthology) | 9.65e-05 | 9 | 49 | 2 | DOID:1407 (biomarker_via_orthology) | |
| Disease | nephritis (biomarker_via_orthology) | 1.47e-04 | 11 | 49 | 2 | DOID:10952 (biomarker_via_orthology) | |
| Disease | renal fibrosis (biomarker_via_orthology) | 1.76e-04 | 12 | 49 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | – | 3.19e-04 | 16 | 49 | 2 | 609423 | |
| Disease | Susceptibility to HIV infection | 3.19e-04 | 16 | 49 | 2 | cv:C1836230 | |
| Disease | bipolar disorder (is_implicated_in) | 1.07e-03 | 29 | 49 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 1.30e-03 | 32 | 49 | 2 | EFO_0021870 | |
| Disease | Mitral valve prolapse | 1.64e-03 | 36 | 49 | 2 | HP_0001634 | |
| Disease | ascending aortic diameter | 1.64e-03 | 140 | 49 | 3 | EFO_0021787 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QNSNVILFCDMCNLA | 226 | O95696 | |
| ALMANFLTQGQVCCN | 276 | P49189 | |
| NCTFTIKLNNTMNAC | 186 | Q8IZP9 | |
| AINFNCGMLLLTCIS | 126 | P51684 | |
| SNMCINNTLVCNGLQ | 301 | Q8TDF5 | |
| CAQSARCLVNFNILM | 96 | Q9Y5G6 | |
| CGLNEFNKLGLNQCM | 556 | Q8TD19 | |
| CMHNNGQCGQLCLAI | 906 | O75197 | |
| LNLTCGNLLCTVVNM | 46 | Q8NDV2 | |
| ICQTLMQDQQTLSCL | 1016 | Q15154 | |
| LCSVLTQDFCMLFNN | 911 | Q9UHC1 | |
| QCQQQSVCSQMLRGL | 56 | Q96LB9 | |
| INLENGELCMNSAQC | 26 | P04118 | |
| CQTMLLIQLPFCGNN | 156 | Q8NH79 | |
| QLSMCFSNVNCCLDV | 271 | Q9Y2T6 | |
| MFLFGIQNNCSQLLT | 1446 | O94916 | |
| CFTVISNQMCQGQLS | 186 | P35555 | |
| AALAVLLCTMALCNQ | 6 | P10147 | |
| CFTQVNNQMCQGQLT | 216 | P35556 | |
| NNGQCWCLLMLLSVS | 6 | P39059 | |
| QMCKNSQDIICSNAG | 141 | O95965 | |
| GQSCLAALSTACQNM | 821 | Q10571 | |
| NGSMDNVCLFLNLAN | 251 | P21281 | |
| SSCQKAMFQCGLLQQ | 301 | O60763 | |
| AMFQCGLLQQLCTIL | 306 | O60763 | |
| SMGCAFINLCILASQ | 61 | Q6UW68 | |
| CINCLQNTMGINCET | 361 | P25391 | |
| AAACMLQLDGLIQQC | 186 | Q8NEA9 | |
| SNMCINNSLVCNGVQ | 306 | Q8NC67 | |
| TPCNMNCINANLLTR | 261 | Q6NSI8 | |
| NSNVILFCDMCNLAV | 286 | P55201 | |
| QCDSMLLRNQQLCST | 71 | O95561 | |
| AALAVLLCTMALCNQ | 6 | P16619 | |
| CSLCNYSCNQSMNLK | 446 | Q8N8E2 | |
| NMKQIQLACLSCGLS | 1051 | Q15111 | |
| INLGNTCFMNCIVQA | 366 | Q70EK9 | |
| INLGNTCFMNCIVQA | 81 | A6NNY8 | |
| RGLINLGNTCFMNCI | 176 | Q9UPT9 | |
| LGNTCFMNCIVQALT | 181 | Q9UPT9 | |
| TISMLLGNLNSCCNP | 321 | P47901 | |
| NLGNTCFMNSALQCL | 306 | Q13107 | |
| CFMNSALQCLSNTAP | 311 | Q13107 | |
| TCQVCQMLLPNQCSF | 741 | Q92610 | |
| CSNMVQEFLLQCLCQ | 291 | A2RTY3 | |
| NTCFMNSAIQCLSNT | 296 | Q9Y4E8 | |
| QTDCYNNLAACLLQM | 71 | Q8N5M4 | |
| LRNLGNTCFMNAILQ | 161 | Q9Y6I4 | |
| NLGNTCFMNSILQCL | 271 | O75604 | |
| NLGNTCYMNSILQCL | 781 | P40818 | |
| NTCFMNSALQCLSNV | 316 | P51784 | |
| NLGNTCFMNSSIQCV | 536 | P35125 | |
| LLCILMFCNQQSVCD | 841 | Q5VZL5 | |
| KSQMNCNLGTCQLQR | 5336 | Q9UKN1 | |
| LAQSLGNMNQICVCI | 261 | Q96D46 |